{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:08:41Z","timestamp":1790791721316,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["americanjournalofsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Surgery"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.amjsurg.2013.07.020","type":"journal-article","created":{"date-parts":[[2013,9,24]],"date-time":"2013-09-24T03:03:10Z","timestamp":1379991790000},"page":"847-852","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["Weight-based enoxaparin dosing for venous thromboembolism prophylaxis in the obese trauma patient"],"prefix":"10.1016","volume":"206","author":[{"given":"Annika","family":"Bickford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Majercik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Bledsoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Dickerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjsurg.2013.07.020_bib1","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM199609053351003","article-title":"A\u00a0comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma","volume":"335","author":"Geerts","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjsurg.2013.07.020_bib2","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1056\/NEJM199412153312401","article-title":"A\u00a0prospective study of venous thromboembolism after major trauma","volume":"331","author":"Geerts","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjsurg.2013.07.020_bib3","first-page":"446","article-title":"Use of low molecular weight heparin in preventing thromboembolism in trauma patients","volume":"41","author":"Knudson","year":"1996","journal-title":"J\u00a0Trauma"},{"key":"10.1016\/j.amjsurg.2013.07.020_bib4","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.amjmed.2005.03.012","article-title":"Obesity as a risk factor in venous thromboembolism","volume":"118","author":"Stein","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.amjsurg.2013.07.020_bib5","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/01.sla.0000137138.40116.6c","article-title":"Thromboembolism after trauma","volume":"240","author":"Knudson","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.amjsurg.2013.07.020_bib6","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1381\/096089205774859245","article-title":"Enoxaparin for thromboprophylaxis in morbidly obese patients undergoing bariatric surgery: findings of the prophylaxis against VTE outcomes in bariatric surgery patients receiving enoxaparin (PROBE) study","volume":"15","author":"Hama","year":"2005","journal-title":"Obes Surg"},{"key":"10.1016\/j.amjsurg.2013.07.020_bib7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.thromres.2009.02.003","article-title":"Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-ill patients","volume":"125","author":"Rondina","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.amjsurg.2013.07.020_bib8","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1001\/archinte.168.15.1678","article-title":"Overweight, obesity, and the risk of recurrent venous thromboembolism","volume":"168","author":"Eichinger","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjsurg.2013.07.020_bib9","doi-asserted-by":"crossref","first-page":"e24S","DOI":"10.1378\/chest.11-2291","article-title":"Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Garcia","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.amjsurg.2013.07.020_bib10","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1345\/aph.1L194","article-title":"Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings","volume":"43","author":"Nutescu","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjsurg.2013.07.020_bib11","doi-asserted-by":"crossref","first-page":"141s","DOI":"10.1378\/chest.08-0689","article-title":"Parenteral anticoagulants: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)","volume":"133","author":"Hirsh","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.amjsurg.2013.07.020_bib12","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/bjs.4068","article-title":"Enoxaparin effect depends on body-weight and current doses may be inadequate in obese patients","volume":"90","author":"Frederiksen","year":"2003","journal-title":"Br J Surg"},{"key":"10.1016\/j.amjsurg.2013.07.020_bib13","first-page":"1167","article-title":"Optimal dose of enoxaparin in critically ill trauma and surgical patients","volume":"58","author":"Rutherford","year":"2005","journal-title":"J\u00a0Trauma"},{"key":"10.1016\/j.amjsurg.2013.07.020_bib14","first-page":"874","article-title":"Standard prophylactic enoxaparin dosing leads to inadequate anti-Xa levels and increased deep venous thrombosis rates in critically ill trauma and surgical patients","volume":"68","author":"Malinoski","year":"2010","journal-title":"J\u00a0Trauma"},{"key":"10.1016\/j.amjsurg.2013.07.020_bib15","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1007\/s00464-008-9997-6","article-title":"Comparison of two low-molecular-weight heparin dosing regimens for patients undergoing laparoscopic bariatric surgery","volume":"22","author":"Simone","year":"2008","journal-title":"Surg Endosc"},{"key":"10.1016\/j.amjsurg.2013.07.020_bib16","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.soard.2007.11.010","article-title":"Enoxaparin thromboprophylaxis in gastric bypass patients: extended duration, dose stratification, and antifactor Xa activity","volume":"4","author":"Borkgren-Okonek","year":"2008","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.amjsurg.2013.07.020_bib17","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s11695-007-9381-y","article-title":"Anti-Xa levels in bariatric surgery patients receiving prophylactic enoxaparin","volume":"18","author":"Rowan","year":"2008","journal-title":"Obes Surg"},{"key":"10.1016\/j.amjsurg.2013.07.020_bib18","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1345\/aph.1Q313","article-title":"Implementation of an enoxaparin protocol for venous thromboembolism prophylaxis in obese surgical intensive care unit patients","volume":"45","author":"Ludwig","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjsurg.2013.07.020_bib19","unstructured":"ARUP National Reference Laboratory. Heparin anti-Xa, low molecular weight heparin. Available at: http:\/\/www.aruplab.com\/guides\/ug\/tests\/0030144.jsp. Accessed February 24, 2013."},{"key":"10.1016\/j.amjsurg.2013.07.020_bib20","first-page":"932","article-title":"Surveillance bias and deep vein thrombosis in the national trauma data bank: the more we look, the more we find","volume":"64","author":"Pierce","year":"2008","journal-title":"J\u00a0Trauma"},{"key":"10.1016\/j.amjsurg.2013.07.020_bib21","first-page":"27","article-title":"Duplex ultrasound screening for deep vein thrombosis in asymptomatic trauma patients: a survey of individual trauma surgeon opinions and current trauma center practices","volume":"70","author":"Haut","year":"2011","journal-title":"J\u00a0Trauma"},{"key":"10.1016\/j.amjsurg.2013.07.020_bib22","first-page":"1336","article-title":"Pharmacokinetics and pharmacodynamics of enoxaparin in multiple trauma patients","volume":"59","author":"Haas","year":"2005","journal-title":"J\u00a0Trauma"},{"key":"10.1016\/j.amjsurg.2013.07.020_bib23","first-page":"128","article-title":"Dose adjusting enoxaparin is necessary to achieve adequate venous thromboembolism prophylaxis in trauma patients","volume":"74","author":"Constantini","year":"2013","journal-title":"J\u00a0Trauma"},{"key":"10.1016\/j.amjsurg.2013.07.020_bib24","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2165\/00003088-200342120-00003","article-title":"Pharmacodynamic and pharmacokinetic properties of enoxaparin","volume":"42","author":"Fareed","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.amjsurg.2013.07.020_bib25","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1067\/mcp.2002.127114","article-title":"The pharmacokinetics and pharmacodynamics of enoxaparin in obese volunteers","volume":"72","author":"Sanderink","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.amjsurg.2013.07.020_bib26","first-page":"1509","article-title":"Thrombelastography versus antifactor Xa levels in the assessment of prophylactic-dose enoxaparin in critically ill patients","volume":"66","author":"Van","year":"2009","journal-title":"J\u00a0Trauma"}],"container-title":["The American Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961013004340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961013004340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:02:28Z","timestamp":1757700148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002961013004340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0002961013004340"],"URL":"https:\/\/doi.org\/10.1016\/j.amjsurg.2013.07.020","relation":{},"ISSN":["0002-9610"],"issn-type":[{"value":"0002-9610","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Weight-based enoxaparin dosing for venous thromboembolism prophylaxis in the obese trauma patient","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjsurg.2013.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}